KESIMPTA

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 7424440cb1104de5
Drug Approval Canada Name: KESIMPTA
Product Name: KESIMPTA
Status: Marketed
Status Date: 2021-04-08
Original Market Date: 2021-04-08
Din: 02511355
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 92:20.00
Atc Original: L04AG12 OFATUMUMAB
Atc Name: l 04 ag 12
Aig Number: 0153129002
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

OFATUMUMAB

20 MG / 0.4 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7424440cb1104de5

Type

Standard